Vaccination Response Modulation With a Targeted Rapamycin Protocol Study

Clinical trial NCT07587801 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07587801
Sponsor: Central Adelaide Local Health Network Incorporated
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Vaccine Immune Response Haemodialysis Patients Older Adults

Start date: 2026-05-01
Primary completion: 2026-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.